header-logo header-logo

07 January 2010 / Roger Birch
Issue: 7399 / Categories: Features , Regulatory
printer mail-detail

A class apart

Roger Birch on the misperceptions in defining medicinal products

There are a number of serious misperceptions upon which products are caught by the definition of what is a medicinal product. This is a serious matter and leads to confusion among members of the public and those who sell such substances which they believe are not caught by the Misuse of Drugs Act 1971, Sch 2.

The Medicines Act 1968 (MA 1968) seems to be forgotten when a particular product is being offered for sale and/or placed on the market.

Let us take the substance BZP as an example.

On the 20 March 2007 a press release was issued by MHRA. They stated that BZP (PEP) pills are dangerous and illegal The press release then states that “any other pills containing Piperazine…or its salts or derivatives would be classified as unlicensed…”.

There then appears in the Mail Online an article dated the 20 March 2007 where the MHRA state that “people are being bamboozled into thinking that BZP is safe because they are being billed

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Flint Bishop—Charlotte Harris

Flint Bishop—Charlotte Harris

Sheffield expansion continues with appointment of commercial property partner

Browne Jacobson—Paul Duggan

Browne Jacobson—Paul Duggan

Browne Jacobson strengthens banking and finance practice with latest partner appointment Paul Duggan

Ward Hadaway—Chris Piggott

Ward Hadaway—Chris Piggott

Employment partner joins Ward Hadaway

NEWS
The Law Society RFC Festival of Sport returns next month, bringing together legal and financial services professionals for one of the sector’s largest annual sporting events
Legal aid deserts leave almost one in four without adequate access to justice
The Solicitors Regulation Authority (SRA) has warned solicitors and law firms that using artificial intelligence does not alter their professional obligations, amid concerns over inaccurate legal material and client confidentiality
From forgotten interest claims to case-management appeals, a string of procedural developments offers useful—and occasionally cautionary—lessons for practitioners

Jonathan Fisher KC highlights that it now accounts for around 40% of criminal offences, with roughly 70% involving technology, and argues that the UK cannot simply prosecute its way out of the problem. Detection, investigation and prosecution all require improvement, while different fraud types demand tailored responses.

back-to-top-scroll